121 related articles for article (PubMed ID: 36253399)
1. Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Rüschoff JH; Haberecker M; Tsourti Z; Nackaerts K; de Perrot M; Brcic L; Nadal E; Tsimpoukis S; Gray SG; Ampollini L; Aerts JG; Felley-Bosco E; Kirschner MB; Monkhorst K; Weynand B; Bavaghar-Zaeimi F; Samarzija M; Llatjos R; Finn SP; Silini E; von der Thüsen J; Marti N; Vervita K; Kammler R; Peters S; Stahel RA; Baas P; Opitz I;
Mod Pathol; 2022 Dec; 35(12):2033. PubMed ID: 36253399
[No Abstract] [Full Text] [Related]
2. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Rüschoff JH; Haberecker M; Tsourti Z; Nackaerts K; de Perrot M; Brcic L; Nadal E; Tsimpoukis S; Gray SG; Ampollini L; Aerts JG; Felley-Bosco E; Kirschner MB; Monkhorst K; Weynand B; Bavaghar-Zaeimi F; Samarzija M; Llatjos R; Finn SP; Silini E; von der Thüsen J; Marti N; Vervita K; Kammler R; Peters S; Stahel RA; Baas P; Opitz I;
Mod Pathol; 2022 Dec; 35(12):1888-1899. PubMed ID: 36115922
[TBL] [Abstract][Full Text] [Related]
3. A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.
Popat S; Curioni-Fontecedro A; Dafni U; Shah R; O'Brien M; Pope A; Fisher P; Spicer J; Roy A; Gilligan D; Gautschi O; Nadal E; Janthur WD; López Castro R; García Campelo R; Rusakiewicz S; Letovanec I; Polydoropoulou V; Roschitzki-Voser H; Ruepp B; Gasca-Ruchti A; Peters S; Stahel RA
Ann Oncol; 2020 Dec; 31(12):1734-1745. PubMed ID: 32976938
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and clinical association of MET gene overexpression and amplification in patients with NSCLC: Results from the European Thoracic Oncology Platform (ETOP) Lungscape project.
Bubendorf L; Dafni U; Schöbel M; Finn SP; Tischler V; Sejda A; Marchetti A; Thunnissen E; Verbeken EK; Warth A; Sansano I; Cheney R; Speel EJM; Nonaka D; Monkhorst K; Hager H; Martorell M; Savic S; Kerr KM; Tan Q; Tsourti Z; Geiger TR; Kammler R; Schulze K; Das-Gupta A; Shames D; Peters S; Stahel RA;
Lung Cancer; 2017 Sep; 111():143-149. PubMed ID: 28838386
[TBL] [Abstract][Full Text] [Related]
5. Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP).
Stahel R; Baas P; Faivre-Finn C; Dooms C; Passlick B; Mazières J; Cappuzzo F; Früh M; Sorensen JB; Blackhall F; Taron M; Gridelli C; O'Byrne K; Rosell R
Lung Cancer; 2010 Apr; 68(1):121-4. PubMed ID: 20138388
[No Abstract] [Full Text] [Related]
6. pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer.
Park CS; Choi J; Seong MK; Hong SE; Kim JS; Park IC; Seol H; Noh WC; Kim HA
Endocr Connect; 2019 Jul; 8(7):863-869. PubMed ID: 31252399
[TBL] [Abstract][Full Text] [Related]
7. Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting.
Gridelli C; Stahel R; Besse B; Ciardiello F; Felip E; Gasparini S; Graziano P; Rossi A; de Marinis F
Lung Cancer; 2011 Dec; 74(3):544-8. PubMed ID: 21958448
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma.
de Vicente JC; Peña I; Rodrigo JP; Rodríguez-Santamarta T; Lequerica-Fernández P; Suárez-Fernández L; Allonca E; García-Pedrero JM
Head Neck; 2017 Sep; 39(9):1876-1887. PubMed ID: 28675642
[TBL] [Abstract][Full Text] [Related]
10. Ordered multisite phosphorylation of Xenopus ribosomal protein S6 by S6 kinase II.
Wettenhall RE; Erikson E; Maller JL
J Biol Chem; 1992 May; 267(13):9021-7. PubMed ID: 1577739
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
Klingebiel M; Dinekov M; Köhler C
Brain Res; 2017 Mar; 1659():121-135. PubMed ID: 28119058
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of ribosomal protein S6 in the aquatic fungus Blastocladiella emersonii.
Bonato MC; da Silva AM; Maia JC; Juliani MH
Eur J Biochem; 1984 Nov; 144(3):597-606. PubMed ID: 6092077
[TBL] [Abstract][Full Text] [Related]
13. A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
Banna GL; Addeo A; Zygoura P; Tsourti Z; Popat S; Curioni-Fontecedro A; Nadal E; Shah R; Pope A; Fisher P; Spicer J; Roy A; Gilligan D; Gautschi O; Janthur WD; López-Castro R; Roschitzki-Voser H; Dafni U; Peters S; Stahel RA
Lung Cancer; 2022 Jul; 169():77-83. PubMed ID: 35660972
[TBL] [Abstract][Full Text] [Related]
14. GDNF signaling in subjects with minimal motor deficits and Parkinson's disease.
Chu Y; Kordower JH
Neurobiol Dis; 2021 Jun; 153():105298. PubMed ID: 33684514
[TBL] [Abstract][Full Text] [Related]
15. The phosphorylation of ribosomal protein S6 by protein kinases from cells infected with pseudorabies virus.
Katan M; McGarvey MJ; Stevely WS; Leader DP
Biochem J; 1986 Oct; 239(1):205-11. PubMed ID: 3026369
[TBL] [Abstract][Full Text] [Related]
16. The activity of protein kinases from hamster fibroblasts towards a synthetic peptide based on a carboxy-terminal portion of ribosomal protein S6.
Munro J; Campbell DG; Leader DP
Biochim Biophys Acta; 1990 Sep; 1054(2):225-30. PubMed ID: 2400783
[TBL] [Abstract][Full Text] [Related]
17. [Clinico-pathological prognostic factors in malignant pleural mesothelioma].
Nakano K; Shiota Y; Ono T; Taniyama K; Hiramoto T; Yamakido M
Nihon Kokyuki Gakkai Zasshi; 2007 Feb; 45(2):153-9. PubMed ID: 17352172
[TBL] [Abstract][Full Text] [Related]
18. Different cytoplasmic/nuclear distribution of S6 protein phosphorylated at S240/244 and S235/236.
Rosner M; Fuchs C; Dolznig H; Hengstschläger M
Amino Acids; 2011 Feb; 40(2):595-600. PubMed ID: 20625781
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated kinase II mediates multiple phosphorylation of ribosomal protein S6 in reticulocytes.
Perisic O; Traugh JA
J Biol Chem; 1983 Nov; 258(22):13998-4002. PubMed ID: 6643463
[TBL] [Abstract][Full Text] [Related]
20. The phosphorylation of eukaryotic ribosomal protein S6 by protein kinase C.
Parker PJ; Katan M; Waterfield MD; Leader DP
Eur J Biochem; 1985 May; 148(3):579-86. PubMed ID: 3158521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
